Prescriber Uncertainty as Opportunity to Improve Care of Type 2 Diabetes with Chronic Kidney Disease: Mixed Methods Study
Author:
Funder
Patient-Centered Outcomes Research Institute
Foundation for the National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11606-022-07838-1.pdf
Reference43 articles.
1. American Diabetes Association Professional Practice C, American Diabetes Association Professional Practice C, Draznin B, et al. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S125-S143. https://doi.org/10.2337/dc22-S009.
2. Huang A, Wu X, Orloff J, Min JY, Flory J. Rates of metformin use in stage 3b chronic kidney disease rose after FDA label change. J Gen Intern Med. 2021;36(10):3261-3263. https://doi.org/10.1007/s11606-020-06380-2.
3. Bailey RA, Wang Y, Zhu V, Rupnow MF. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes. 2014;7:415. https://doi.org/10.1186/1756-0500-7-415.
4. Mende CW. Chronic kidney disease and SGLT2 inhibitors: a review of the evolving treatment landscape. Adv Ther. 2022;39(1):148-164. https://doi.org/10.1007/s12325-021-01994-2.
5. Li J, Albajrami O, Zhuo M, Hawley CE, Paik JM. Decision algorithm for prescribing SGLT2 inhibitors and GLP-1 receptor agonists for diabetic kidney disease. Clin J Am Soc Nephrol. 2020;15(11):1678-1688. https://doi.org/10.2215/CJN.02690320.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Information needs for GPs on type 2 diabetes in Western countries: a systematic review;British Journal of General Practice;2024-03-01
2. Optimizing Care Delivery in Patients with Chronic Kidney Disease in the United States: Proceedings of a Multidisciplinary Roundtable Discussion and Literature Review;Journal of Clinical Medicine;2024-02-20
3. Prediction of chronic kidney disease progression using recurrent neural network and electronic health records;Scientific Reports;2023-12-13
4. The underrecognized role of primary care physicians in the prevention and management of chronic kidney disease;Primary Care Diabetes;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3